Curriculum Vitae

PERSONAL DETAILS

ASSOCIATE PROF. DR. SHANGGAR A/L KUPPUSAMY


ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • Committee Member, University Malaya, 01/09/2021 to present
  • Member, Faculty, 01/08/2021 to present
  • Head of Unit, Faculty, 02/11/2020 to present
  • Coordinator, Faculty, 01/07/2020 to present
  • Coordinator, Faculty, 01/07/2020 to present
  • Coordinator, Faculty, 01/07/2020 to present
  • Committee Member _Department Level, Faculty, 01/01/2021 to 31/12/2021
  • Honorary Secretary, National, 27/12/2020 to present
  • BOARD MEMBER, National, 01/11/2020 to present
  • Committee member of Malaysian Urological Association, National, 16/12/2018 to 15/12/2020
  • Honorary Secretary Malaysia Urological Foundation (MUF), National, 01/07/2018 to 31/12/2020
  • Examiner - Malaysian Urological Association , National, 03/11/2019 to 03/11/2019
  • Chairperson - 17th Urological Association of Asia Congress 2019, International, 07/08/2019 to 10/08/2019
  • Facilitator- A Teacher's Toolkit Workshop, University Malaya, 19/06/2019 to 19/06/2019
  • Facilitator-1st Onco Summit 2019, National, 12/01/2019 to 12/01/2019
  • Chairman, Faculty, 28/09/2015 to 31/12/2018
  • Committee member- Research Committee, Faculty, 02/03/2015 to 31/12/2018
  • Head Coordinator, Faculty, 06/01/2016 to 31/12/2016
  • Head Coordinator, Faculty, 01/10/2015 to 31/12/2016
  • Coordinator- Phase II MBBS, Faculty, 01/11/2008 to present
  • Committee member- Prostate Awareness Campaign 2006 & 2007, University Malaya,   to present
  • Member- Hospital Transfusion Committee, University Malaya,   to present
  • Organising Committee Member - UM Wellness Campaign 2008, University Malaya,   to present
  • Coordinator- Hospital Information System, Faculty,   to present
  • Committee Member- Malaysian Urological Conference Organizing committee,   to present
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • Doctoral Degree (PhD), LAIN-LAIN BIDANG PERUBATAN, UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL
  • FRCS (Urol)(Glasg.), UROLOGY, ROYAL COLLEGE OF PHYSICIANS & SURGEONS OF GLASGOW
  • MS, SURGERY, UNIVERSITI MALAYA (UM)
  • MBBS, MEDICINE, KASTURBA MEDICAL COLLEGE, INDIA
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
  • Life member, Member, Since 2018 (National)
  • General Medical Council, Member, Since 2010 (International)
  • Malaysian Medical Association, Life Member, Since 2009 (National)
  • National Transplant Advisory Council, Committee Member, 2021 to present (National)
  • Subspecialty Education Subcommittees, Member, 2020 to 2022 (National)
  • Elected Honorary Secretary, Secretary, Since 2018 (National)
  • Advisor to Organising committee-Endourology in the COVID ERA, Advisory Board, 2021 to 2021 (International)
  • University Malaya Academic Club (UMAC), Member, 2021 to 2021 (University)
  • Urological Association of Asia, Active Member, 2017 to 2020 (International)
  • European Association of Urology, Member, 2018 to 2019 (International)
SPECIALIZATION
(Area)
Area of Expertise
  • UROLOGY (Board of Urology Malaysia)
  • UROLOGY
    • TEACHING
    (Course Title),(Level of Study),(Institution),(Academic Session)
    Teaching
  • DXED3102 - HUMAN DISEASE, Bachelor/First Degree, University of Malaya (UM) (2008 - 1)
  • DXED3102 - HUMAN DISEASE, Bachelor/First Degree, University of Malaya (UM) (2014 - 2)
  • DXED3102 - HUMAN DISEASE, Bachelor/First Degree, University of Malaya (UM) (2009 - 1)
  • DXED3102 - HUMAN DISEASE, Bachelor/First Degree, University of Malaya (UM) (2016 - 2)
    • Teaching Activity
  • MTA27500 - ADVANCED CLINICAL TRAINING, Master, University Malaya (2021)
  • MIA - Bachelor of Medicine, Bachelor of Surgery, Bachelor/First Degree, University Malaya (2021)
  • MTA2781A - RESEARCH REPORT, Master, University Malaya (2021)
    • PUBLICATIONS
    (Title of publication in APA style)
    WoS
    2021
    • Chai, C. A., Yeoh, W. S., Rajandram, R., Aung, K. P., Ong, T. A., Kuppusamy, S., . . . Teoh, J. Y. (2021). Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study. Frontiers in Surgery, 8, 6. doi: 10.3389/fsurg.2021.659292
    • Schutz, F. A. B., Sirachainan, E., Kuppusamy, S., Hoa, N. T. T., Dejthevaporn, T., Bahadzor, B., . . . Garg, A. (2021). Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel. Therapeutic Advances in Medical Oncology, 13, 13. doi: 10.1177/1758835920985464
    2020
    • Yii, R. S. L., Lim, J., Sothilingam, S., Yeoh, W. S., Fadzli, A. N., Ong, T. A., . . . Razack, A. H. A. (2020). Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia. Asian Journal of Surgery, 43(1), 87-94. doi: 10.1016/j.asjsur.2019.02.014
    • Perumal, K., Mun, K. S., Yap, N. Y., Razack, A. H. A., Gobe, G. C., Ong, T. A., . . . Rajandram, R. (2020). A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma. BioMed Research International, 2020, 10. doi: 10.1155/2020/3682086
    • Phyo, A. K., Mun, K. S., Kwan, K. C., Ann, C. C., & Kuppusamy, S. (2020). Genitourinary extramammary Paget's disease: review and outcome in a multidisciplinary setting. International Journal of Clinical and Experimental Pathology, 13(9), 2369-2376.
    2019
    • Tan, J. S. J., Ong, K. C., Ong, D. B. L., Wu, Y. S., Razack, A., Kuppusamy, S., . . . Rhodes, A. (2019). Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer. Malaysian Journal of Pathology, 41(3), 243-251.
    2010
    • Kuppusamy, S., Faizal, N., Quek, K. F., Razack, A. H., Dublin, N. (2010). The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound biopsy of prostate: a prospective randomised control study, World Journal of Urology. 28(6), 673-676
    Refereed Journals
    2021
    • Optimizing Outcomes for Patients with Metastatic Prostate Cancer: Insights from South East Asia Expert Panel (WoS)
    • Chai CA, Yeoh WS, Rajandram R, Aung KP, Ong TA, Kuppusamy S, Nazran A, Kumaran K, Razack AHA, Teoh JY (2021). Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study. Frontiers of Surgery 8: 659292. doi: 10.3389/fsurg.2021.659292. (WoS)
    • Amat, N., Philip, E.F., Chai, C.A., Yeoh, W.S., Lim, J., Fadzli, A.N., Kuppusamy, S. & Ong, T.A. (2021). The impact of population lockdown on the referral pattern for urology in a COVID-19 designated tertiary hospital in Malaysia. Urological Science, 32(1), 23-26.
    2020
    • Aung KP, Mun KS, Kong CK, Chai CA, Shanggar K. (2020). Genitourinary extramammary Paget's disease: review and outcome in a multidisciplinary setting. Int J Clin Exp Pathol, 13 (9): 2369 - 2376 (WoS)
    • Yii, R., Lim, J., Sothilingam, S., Yeoh, W. S., Fadzli, A. N., Ong, T. A., Kuppusamy, S., & Abdul Razack, A. H. (2020). Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia. Asian journal of surgery, 43(1), 87 94. https://doi.org/10.1016/j.asjsur.2019.02.014 (WoS)
    • Perumal, K., Mun, K. S., Yap, N. Y., Razack, A., Gobe, G. C., Ong, T. A., Kuppusamy, S., & Rajandram, R. (2020). A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma. BioMed research international, 2020, 3682086. https://doi.org/10.1155/2020/3682086 (WoS)
    2019
    • Tan JSJ, Ong KC, Ong DBL, Wu YS, Razack A, Kuppusamy S, Lim J, Rhodes A (2019) Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer. Malaysian J Pathol. 41 (3): 243 - 251 (WoS)
    • Yii RSL et al., Predictive factors of prostate cancer diagnosis with PSA 4.0e10.0 ng/ml in a multi-ethnic Asian population, Malaysia, Asian Journal of Surgery, https://doi.org/10.1016/j.asjsur.2019.02.014 (WoS)
    • Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer (WoS)
    2018
    • Kuppusamy S, Quek KF, Rajandram R, Razack AHA and Dublin N (2018). Revisiting prostate specific antigen density (PSAD): a prospective analysis in predicting the histology of prostate biopsy. International Journal of Clinical and Experimental Medicine (Accepted) (WoS)
    2017
    • Prevathe Poniah, Shamsul Mohd Zain, Azad Hassan Abdul Razack, Shanggar Kuppusamy, Shankar Karuppayah, Hooi Sian Eng, Zahurin Mohamed: Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer. Urologic Oncology 05/2017;, DOI:10.1016/j.urolonc.2017.04.017 (WoS)
    • Dublin N and Kuppusamy S. Dilatation/urethotomy/meatomy - indications and outcomes (Non-WoS/Non-SCOPUS)
    2015
    • Poniah P, Mohamed Z, Apalasamy YD, Zain SM, Kuppusamy S, Razack AHA. Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. Int J Clin Exp Med. 2015; 8(10): 19232-40. (WoS)
    2013
    • Ibrahim, Fatimah; Sian, Tee Chee; Shanggar, Kuppusamy; Razack, Azad Hassan. 2013. Muslim Prayer movement as an alternative therapy in the treatment of erectile dysfunction: A preliminary study. J. Phys. Ther. Sci. 25: 1087-1091. (WoS)
    2011
    • Kuppusamy S, Gillatt D.Managing patients with acute urinary retention.Practitioner 2011; 255(1739):21-23. (SCOPUS)
    2010
    • Shanggar Kuppusamy, Faizal N, Quek, KF; Razack, AH; Dublin, N.2010 The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound (TRUS) biopsy of prostate: a prospective randomized study. World J Urol. Published Online 11th July 2010. (WoS)
    • K Shanggar, MZ Zulkifli, AH Razack, N Dublin. Granulomatous Prostatitis: A Reminder to Clinicians. Med J Malaysia Vol 65, No 1, March 2010, 21-22. (Non-WoS/Non-SCOPUS)
    • Shanggar K, Ng CH, Razack AH, Dublin N. Squamous Cell Carcinoma of Scrotum: a rare case of scrotal neoplasm.2010 Journal of the University of Malaya Medical Centre; Vol 13, Number 1, 59-62. (SCOPUS)
    2008
    • Koh PS, Shanggar K, Razack AH, Lee G.2008.Congenital Bilateral Aplasia of Vas Deferens (CBAVD): A Reminder to Clinicians. Journal of the University of Malaya Medical Centre Vol 11(2):89-90. (Non-WoS/Non-SCOPUS)
    2007
    • Shanggar K, Muhilan P, Dublin N, Eng Geap George Lee, Razack AH. An Unusual Presentation of a Rare Rhabdomyosarcoma of Urinary Bladder and Prostate. Journal of the University of Malaya Medical Centre; Vol 10, Number 2, 2007, 57-59. (Non-WoS/Non-SCOPUS)
    Article in Proceedings
    2013
    • Kuppusamy S, White P, Razack A, Gillatt D, Rhodes A, Doran O.Single Nucleotide Polymorphism (SNP) in CYP17A1 (rs743572) Gene as a Risk of Prostate Cancer Development A Preliminary Report in Caucasian Group (2011). (WoS)
    2010
    • Chee Loong Yeap, K Shanggar, Norman Dublin, Azad H Razack.2010 Sextant vs volume based extended transrectal ultrasound guided prostate biopsy- an experience of University Malaya Medical Centre (UMMC). International J of Urol Vol. 17; Suppl 1; A204-A205. (WoS)
    • Shanggar, K; Quek, KF; Razack, AH; Dublin, N.2010 The usefulness of Prostate Specific Antigen Density in Prostate Cancer detection: A Malaysian perspective. International J of Urol Vol. 17; Suppl 1; A203. (WoS)
    2009
    • S Kuppusamy, K F Quek, A H Razack, N Dublin. Assessment of Diagnostic performance of Prostate Specific Antigen (PSA) in a nation of low Prostate cancer incidence.BJUI 2009 Vol. 103; Suppl 1, Pg 22. (WoS)
    • S Kuppusamy, Faizal N, Quek, KF; Razack, AH; Dublin, N. The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound (TRUS) biopsy of prostate: a prospective randomized trial.2009 BJUI Vol. 103; Suppl 4, Pg 13. (WoS)
    2008
    • Shanggar K, Pavai S, Jayalakshmi P, Razack AH, Dublin N. 2008. The Use of Various Prostate Specific Antigen (PSA) Forms for Estimation of Prostate Cancer Risk. Indian Journal of Urology; Vol. 24, Suppl. 2, S131. (SCOPUS)
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    Clinical Trial (CIC)
  • A Phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-B15 / EV-304), Co-Researcher, 25/05/2021 to 31/12/2026, Merck Sharp & Dohme (M) Sdn. Bhd.
    • Johnson & Johnson
  • PREVALENCE : A biomarker study to determine frequency of DNA-repair defects in men with metastatic prostate cancer. , Consultant, 2020 - 2024 (International)
    • Private Funding
  • Linguistic Translation and Validation of EORTC QLQ PR25 Questionnaire in Malay and Malaysian Chinese Language, Supervisor, 2019 - 2021 (National)
  • A Phase IV Interventional Safety, Efficacy and Quality of Life Study of ELIGARD in Prostate Cancer Patients in Asia (ELIGANT), Consultant, 2017 - 2020 (National)
  • A PHASE III, MULTICENTRE, RANDOMISED, DOUBLE BLIND, PARALLEL GROUP, PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONE OR MORE INTRADETRUSOR TREATMENTS OF 600 OR 800 UNITS OF DYSPORT FOR THE TREATMENT OF URINARY INCONTINENCE IN SUBJECTS WITH NEUROGENIC DETRUSOR OVERACTIVITY DUE TO SPINAL CORD INJURY OR MULTIPLE SCLEROSIS, Consultant, 2016 - 2020 (National)
  • A multicenter, prospective, longitudinal registry of patients with Prostate Cancer in Asia, Consultant, 2016 - 2020 (National)
    • Merck Sharp & Dohme (M) Sdn. Bhd
  • KEYNOTE-676 : Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette-Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction (KEYNOTE-676), Consultant, 2019 - 2024 (International)
    • MKS Medic Sdn Bhd
  • Comparing the DIfference in Detrusor Pressures at Maximal Flow Rate Between Air-Charged vs Water-Charged Catheters, Consultant, 2019 - 2021 (National)
    • International Funding
  • Robotic-a ssisted percutaneous access Interventional, non-randomized, open-label, non-comparative and First-in-Man Study, Consultant, 2018 - 2018 (International)
  • A multi-centre, prospective, longitudinal registry of patients with prostate cancer in Asia, Consultant, 2015 - 2020 (International)
    • Fundamental Research Grant Scheme (FRGS)
  • The expression of H3K27 demethylases from samples of renal cell carcinoma and bladder cancer patients., Principal Investigator(PI), 2017 - 2019 (National)
  • Construing The Roles Of Adipokines And Their Mechanism In Renal Cell Carcinoma (rcc), Co-Researcher, 01/11/2020 to 30/04/2024, Kementerian Pendidikan Tinggi (KPT) (Government)
  • Investigating The Mechanisms Behind Male Infertility In Hypothyroidism With Obesity: The Role Of Thyroid And Leptin Hormones, Co-Researcher, 01/11/2020 to 30/04/2023, Kementerian Pendidikan Tinggi (KPT) (Government)
  • Establishing the role of histone H3 lysine 27(H3K27) demethylases in renal cell carcinoma and bladder cancers invasiveness and progression, Principal Investigator(PI), 15/08/2017 to 14/09/2019, Kementerian Pendidikan Tinggi (KPT) (Government)
    • Malaysian National Insitute of Health (NIH) Grant
  • Asia Study Group of Prostate Cancer Malaysian Cohort (M-CaP Study) , Consultant, 2017 - 2020 (National)
    • Yayasan Jiwa Malaysia
  • Low Intensity Shock Wave Therapy for Erectile Dysfunction, Principal Investigator(PI), 2016 - 2018 (National)
    • Geran Penyelidikan Universiti Malaya (UMRG)
  • Study of polymorphisms of CYP3A and SRD5A2 genes and their association with risk of prostate cancer among multiethnic Malaysian men, Principal Investigator(PI), 2010 - 2013 (National)
  • Screening of genetic markers in Prostate Cancer in The Malaysian Population , Consultant, 2010 - 2011 (National)
    • Short Term Research Fund (Vote F)(PJP)
  • Prostate Specific Antigen (PSA) and its isoforms in the evaluation of Prostate Cancer, Principal Investigator(PI), 2008 - 2009 (National)
    • RU Geran - Fakulti Program
  • Clinical And Molecular Investigation On The Role Of Cholesterol In Improving Drug Response In Bladder Cancer, Co-Researcher, 15/09/2020 to 14/09/2022, Research University (Government)
    • Others MOHE - Top 100 (IIRG)-HWB
  • Characterization Of Farnesyl Diphosphate Farnesyltransferase 1 (fdft1) Expression In Cisplatin -treated Muscle -invasive Bladder Cancer, Co-Researcher, 13/05/2019 to 12/05/2022, Kementerian Pendidikan Tinggi (KPT) (Government)
    • Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)
  • Molecular profiling and pathway analysis of clinically aggressive Renal Cell Carcinoma , Co-Researcher, 15/11/2017 to 22/04/2020, Research University (Government)
    • SUPERVISION
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Completed
    • Expression of the oncogene ERG (V-ETS Erythroblastosis Virus E26 Oncogene Homolog) and activation of the androgen receptor in prostate cancer, Tan Jia Shin Jessica, University of Malaya (UM) (Post Graduate Student)
    • -, LOW JER WEI, University of Malaya (MASTER)
    • -, VETHUNAN A/L TAMALVANAN, University of Malaya (MASTER)
    • SINGLE NUCLEOTIDE POLYMORPHISMS, COPY NUMBER VARIATION AND PROTEIN PROFILES IN PROSTATE CANCER, PREVATHE A/P PONIAH, University of Malaya (PhD)
    • -, DINESH FRANCIS K BALASINGAM, University of Malaya (MASTER)
    • Genomics and Proteomics of prostate cancer in Malaysian men, Prevathe a/p Poniah, University of Malaya (UM) (Post Graduate Student)
    • -, RAYMOND YII SHI LIANG, University of Malaya (UM) (Post Graduate Student)
    • -, LOW JER WEI, University of Malaya (UM) (Post Graduate Student)
    • SINGLE NUCLEOTIDE POLYMORPHISMS, COPY NUMBER VARIATION AND PROTEIN PROFILES IN PROSTATE CANCER, PREVATHE A/P PONIAH, University of Malaya (UM) (Post Graduate Student)
    • Prevalence of Hypogonadism and Metabolic Syndrome in Non-Urological patients, Dr. Koong Jun Kit, University of Malaya (UM) (Post Graduate Student)
    • Effect of ADT on Prostate cancer patients, Dr. Low Jer Wei, University of Malaya (UM) (Post Graduate Student)
    • -, RAYMOND YII SHI LIANG, University of Malaya (UM) (Post Graduate Student)
    • -, VETHUNAN A/L TAMALVANAN, University of Malaya (UM) (Post Graduate Student)
    • Treatment of ED using LISWT, Dr. Dinesh Francis, University of Malaya (UM) (Post Graduate Student)
    • Assessment of Nocturnal Penile Tumescence in Erectile Dysfunction Patients, Dr. Tee Chee Sian, University of Malaya (UM) (Post Graduate Student)
    • -, RAYMOND YII SHI LIANG, University of Malaya (MASTER)
    Ongoing
    • THE EXPRESSION AND PROGNOSTIC VALUE OF H3 LYSINE 27 (H3K27) DEMETHYLASES IN BOTH RENAL CELL CARCINOMA AND BLADDER CANCERS, REBECCA ANTHONY, University of Malaya (UM) (Post Graduate Student)
    • -, SEI FON SHENG, University of Malaya (MASTER)
    • -, LIM WEI HONN, University of Malaya (MASTER)
    • Adipokines as potential prognostic biomarkers and therapeutic target in renal cell carcinoma (RCC), Sugania Malar Chinapayan, University of Malaya (PhD)
    • -, SEI FON SHENG, University of Malaya (UM) (Post Graduate Student)
    • THE EXPRESSION AND PROGNOSTIC VALUE OF H3 LYSINE 27 (H3K27) DEMETHYLASES IN BOTH RENAL CELL CARCINOMA AND BLADDER CANCERS, REBECCA ANTHONY, University of Malaya (UM) (Post Graduate Student)
    • THE EXPRESSION AND PROGNOSTIC VALUE OF H3 LYSINE 27 (H3K27) DEMETHYLASES IN BOTH RENAL CELL CARCINOMA AND BLADDER CANCERS, REBECCA ANTHONY, University of Malaya (UM) (Post Graduate Student)
    • THE EXPRESSION AND PROGNOSTIC VALUE OF H3 LYSINE 27 (H3K27) DEMETHYLASES IN BOTH RENAL CELL CARCINOMA AND BLADDER CANCERS, REBECCA ANTHONY, University of Malaya (UM) (Post Graduate Student)
    • Linguistic Translation and Validation of EORTC QLQ PR25 Questionnaire in Malay and Malaysian Chinese Language, Lim Wei Honn, University of Malaya (UM) (Post Graduate Student)
    • ASSESMENT OF H3 LYSINE 27 (H3K27) DEMETHYLASES PROTEIN EXPRESSION AS POTENTIAL BIOMARKERS OF BLADDER CANCER, REBECCA ANTHONY, University of Malaya (MASTER)
    • The Expression and Significance of H3 Lysine 27 (H3k27) Demethylases in both Renal Cell Carcinoma and Bladder Cancers : Patients Sample., Rebecca Anthony A/L Anthony Dass, University of Malaya (UM) (Post Graduate Student)
    • Adequacy of current analgesic protocol for Extracorporeal Shockwave Lithotripsy in UMMC, Dr. Vethunan a/l Tamalvanan, University of Malaya (UM) (Post Graduate Student)
    • -, LIEW VIN SERN, University of Malaya (UM) (Post Graduate Student)
    Other
    • , PREVATHE A/P PONIAH, University of Malaya (MASTER)
    UG Student/Clinical Fellowship
    (Title of Thesis),(Academic Session)
    Ongoing
    • Recurrent waves of Covid-19 and its impact on Medical Students: an assessment of awareness and preparedness., 2021
    • The Impact of Recurrent Waves of Covid-19on the Mental Health of Medical Students: A Cross-Sectional Study, 2021
    PATENT/IPR
    (Product Name),(Type),(Level)
    • USE OF INDICES RELATING TO LEVELS OF SERUM AND URINARY FRAGMENT PEPTIDES OF INTER-ALPHA TRYPSIN INHIBITOR LIGHT AND HEAVY CHAIN H4 FOR DIAGNOSIS AND/OR DISCRIMINATION OF PROSTATE CANCER, PATENT
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • Speaker - Prostate Cancer Society Malaysia, 17/10/2021 to 17/10/2021 (National)
    • 2nd Blue Cap Run 2016- Organising committee (Deputy Chairman), 06/11/2016 to 06/11/2016
    • 2nd Blue Cap Relay Run 2016, 06/11/2016 to 06/11/2016
    • Projek Tanggungjawab Korporat Di Perkampungan Orang Asli Pulau Indah - Westports, 16/10/2010 to 16/10/2010
    • UM Community Health Awareness Campaign 2010, 06/02/2010 to 07/02/2010
    • Prostate Awareness Campaign, 13/10/2007 to 14/10/2007
    COURSE ATTENDED
    (Course Title),(Venue),(Duration),(Level)
    External Course
  • UAA Virtual Congress 2021, Virtual, 19/08/2021 to 21/08/2021 (International)
    • ACADEMIC/PROFESSIONAL SERVICES
    Academic/Professional Services
    (Contribution),(Duration),(Level),(Role)
  • Prostate biopsy in young patients with hematospermia without an indication for biopsy contributed to the early diagnosis of prostate sarcoma: A case report, 04/09/2021 to 17/09/2021, International, (Reviewer)
  • Internal Examiner for PhD Thesis, 29/08/2021 to 31/10/2021, University, (Internal Examiner)
  • Omental procedures during peritoneal dialysis insertion: a systematic review and meta analysis, 20/08/2021 to 20/08/2021, International, (Reviewer)
  • Internal Examiner Stage 3.3 (Barrier), 17/08/2021 to 19/08/2021, University, (Internal Examiner)
  • The prognosis and clinicopathological features of different distant metastases pattern in renal cell carcinoma: Analysis based on SEER database, 27/06/2021 to 27/06/2021, International, (Reviewer)
  • Prognostic value of copine 1 in patients with renal cell carcinoma, 06/06/2021 to 06/06/2021, International, (Reviewer)
  • Competing risk analysis and survival prediction model construction of metastatic renal cell carcinoma : A retrospective cohort study, 05/06/2021 to 05/06/2021, International, (Reviewer)
  • Internal Examiner for MBBS- Stage 1, 03/06/2021 to 03/06/2021, University, (Internal Examiner)
  • MBBS OSCE Stage 2 Examiner, 27/05/2021 to 27/05/2021, University, (Internal Examiner)
  • Internal Examiner Master of Clinical Oncology, 01/04/2021 to 30/04/2021, University, (Internal Examiner)
  • Exam Question Writting Committee - MBU, 01/01/2021 to 31/12/2021, National, (Expert Advisor)
  • Board Evaluation and Urological Training Governance, 01/11/2020 to 31/12/2022, National, (Internal Examiner)
  • Preliminary study on the relationship between chronic inflammation and biopsy results in prostate biopsy, 21/03/2020 to 25/04/2020, International, (Reviewer)
  • Appointment as Curriculum Writing Committee member for Parallel Entry Urology Programme, 12/09/2017 to 31/12/2021, National, (Resource Person)
  • National Urology Training Curriculum Writing, 07/08/2017 to 31/12/2022, National, (Resource Person)
    • Evaluation Activity
    (Activity),(Duration),(Category)
  • UAA Congress 2019, 2019 to 2019 (Article in Proceeding)
  • Facilitator/Speaker for the Oncological update, 2019 to 2019 (Oncological Summit)
  • Malaysian Journal of Medicine - Transperitoneal Laparoscopic Nephrectomy for Renal Tumour Disease versus Non-Tumour Disease: What are the Differences in Outcomes? , 2019 to 2019 (Article in Journal)
  • Malaysian Journal of Medicine - EXTRAGASTROINTESTINAL STROMAL TUMOUR (EGIST) OF PROSTATE", 2019 to 2019 (Article in Journal)
  • Malaysian Journal of Medicine , 2018 to 2018 (Article in Journal)
  • MBBS Examination, 2018 to 2018 (MBBS OSCE Examination)
  • 8th Urology Update & 1st Workshop for Medical Officer, 2018 to 2018 (Workshop)
  • Olympus Dinner Symposium, 2018 to 2018 (Conference)
  • Formulate scientific programme for UAA 2019 in Kuala Lumpur , 2018 to 2019 (Congress)
  • Advanced Nursing Education Programme, 2018 to 2018 (Lecture)
  • MBU Viva Preparatory course, 2018 to 2018 (Course)
  • Malaysia Urology Board Examiner, 2016 to 2016 (Year 1 & Year 2 Examiner)
  • Expert talk on kidney stones, 2016 to 2016 (Men's Health TV interview)
  • Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP) organized by the Enterostomal Therapist (E.T) Team, University Malaya Medical Center 29 February 2016 27 May 2016, 2016 to 2016 (Expert Speaker)
  • Educational Development for Urologists, 2016 to 2016 (Expert Speaker)
  • Master Medical Science to PhD Conversion Seminar for Ms Yap Ning Yi (MGN130058)., 2015 to 2015 (Project)
    • Academic/Technical Contribution
    (Activity),(Organisation),(Duration),(Role)
  • Visiting Consultant Urologist (For Robotic Surgery) At Sunway Medical Centre, Sunway Medical Centre, 2019 - 2019 (Consultant )
  • Trainer for Advanced Urology Course, Malaysian Urological Association, 2019 - 2019 (Trainer)
    • AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2021 (CERTIFICATE)
    • Appreciation as local organizing committee for MUC 2020, Malaysian Urology Association, 2020 (GENERAL ACHIEVEMENTS)
    • Best Video Presentation, Urological Association of Asia, 2019 (COMPETITION)
    • Best Poster Award, University of Malaya, 2018 (COMPETITION)
    • UAA-Youth Section Fellowship, Urological Association of Asia, 2018 (OTHERS)
    • Best Video Presentation, Malaysian Urological Association, 2018 (RESEARCH)
    • Best Lecturer for Surgery Session 2015/2016, University of Malaya, 2017 (SERVICES)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2017 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2016 (CERTIFICATE)
    • Invited consultant for mass media- Prostate cancer awareness, Astro, 2016 (OTHERS)
    • Invited Consultant for Mass media, Astro, 2016 (OTHERS)
    • Invited consultant for mass media- Prostate cancer treatment, Astro, 2016 (OTHERS)
    • Kecemerlangan Perkhidmatan 2015, Universiti Malaya, 2015 (SERVICES)
    • Most number of participants in a cancer survivor relay run, Malaysia Book of Records, 2015 (RESEARCH)
    • Best Oral Award, Malaysian Urological Association, 2010 (RESEARCH)
    • Best Poster Award at World Video Urology Conference 2009, Malaysian Urological Association, 2009 (RESEARCH)
    • Sanofi-Aventis Prostate Cancer Research Award, Malaysian Urological Association, 2007 (SPECIAL)
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • Train the Trainee - Malaysian Board of Urology, Malaysian Board of Urology, 28/03/2021 to 28/03/2021, Lead Trainer (National)
    • Train the Trainer - Malaysian Board of Urology, Malaysian Board of Urology, 30/01/2021 to 30/01/2021, Lead Trainer (National)
    • Postgraduate Clinical Master Supervisors' Training 2021, Department of Surgery, 27/03/2021 to 27/10/2021, Trainer (National)
    • Malaysian Board of Urology (MBU) Viva Preparatory Course, MALAYSIAN UROLOGICAL ASSOCIATION, 10/07/2021 to 10/07/2021, Trainer (National)
    • Advanced Urology Course, Malaysian Board of Urology, 26/06/2021 to 26/06/2021, Trainer (National)
    • Clinical Evaluation of Intermitent Catheter, Epsilon Medical Devices SDN.BHD, 01/01/2021 to 31/07/2021, Consultant (National)
    • Visiting Consultant for Renal Transplant Programme, Universiti Teknologi Mara, 01/02/2017 (National)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    INVITED SPEAKER
  • Vesico and Ureterovaginal Fistulae, MALAYSIAN ENTEROSTOMAL THERAPY NURSING EDUCATION PROGRAM 2021, 10/09/2021 to 10/09/2021, M&T Network Consultancy Services Sdn. Bhd. (National)
  • An Asian perspective E-based learning an assessment in urology: A new normal, UAA 2021, 19/08/2021 to 21/08/2021, Urological Association of Asia (International)
  • UROCADEMY: An e-assessment module for urological training, EAU 2021, 08/07/2021 to 12/07/2021, The European Association of Urology (International)
  • VVF, MALAYSIAN ENTEROSTOMAL THERAPY NURSING EDUCATION PROGRAM 2020, 03/02/2020 to 03/02/2020, M&T Network Consultancy Services Sdn Bhd and UMMC (National)
  • PhAME 2019 , PhAME 2019 , 14/07/2019 to 14/07/2019, Pfizer Malaysia (National)
  • To explore the possibility to formulate evidence based practical recommendations for the management of mestastatic prostate cancer, SOUTH EAST ASIA PROSTATE CANCER EXPERT MEET, 25/06/2019 to 25/06/2019, South east asia prostate cancer (International)
  • A TEACHER'S TOOLKIT WORKSHOP: FOUNDATIONS OF ASSESSMENTS FOR HEALTH PROFESSIONALS, A TEACHER'S TOOLKIT WORKSHOP: FOUNDATIONS OF ASSESSMENTS FOR HEALTH PROFESSIONALS, 19/06/2019 to 19/06/2019, MEDICAL EDUCATION AND RESEARCH DEVELOPMENT UNIT (MERDU) (University)
  • Prostate Cancer and Its Related Issues, Rotary Club Meeting , 18/04/2017 to 18/04/2017, Rotary Club of Bangsar (National)
  • Management of Erectile Dysfunction in Diabetes, Malaysian Diabetes Educators Society Scientific Conference , 07/04/2017 to 09/04/2017, Malaysian Diabetes Educators Society (National)
  • VVF and UVF, Malaysian Enterostomal Therapy Nursing Education Programme, 22/02/2017 to 22/02/2017, Department of Nursing and Business Development Unit, PPUM (National)
  • Sexual Dysfunction, Men's Health Academy, 26/03/2016 to 27/03/2016, Pfizer (National)
  • Vesico and Uretero Vaginal Fistulae, Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP), 14/03/2016 to 14/03/2016, Enterostomal Therapist Team, UMMC and supported by Malaysian Ostomy Association (MOsA) (International)
    • ORAL PRESENTER
  • Ureterorenoscopy for Ureteric Calculi in Day Surgery An Analysis of 4 years Experience in UMMC, 16th Malaysian Urological Conference, 07/12/2007 to 09/12/2007, Malaysian Urological Association (National)
  • Construction of Malay Version Of The Overactive Bladder Screener For Assessing Urinary Tract Symptoms in a Malaysian Population, 40th Malaysia-Singapore Congress of Medicine, 25/08/2006 to 27/08/2006, Academy of Medicine of Malaysia (International)
    • POSTER PRESENTER
  • Restoring Sexual Function in Female with Pelvic Floor Tumour: A Sigmoid Colon Neovaginoplasty, 16th Malaysian Urological Conference, 07/12/2007 to 09/12/2007, Malaysian Urological Association (National)
  • Renal Secondary of Metastatic Uterine Cervix Carcinoma Presented As A Non-resolving Abscess, 16th Malaysian Urological Conference, 07/12/2007 to 09/12/2007, Malaysian Urological Association (National)
  • Extramammary Paget s disease: A Rare Series of 4 Peno-scrotal Neoplasm, 16th Malaysian Urological Conference, 07/12/2007 to 09/12/2007, Malaysian Urological Association (National)
    • PRESENTER
  • Sextant vs volume based extended transrectal ultrasound guided prostate biopsy- an experience of University Malaya Medical Centre (UMMC)., Asian Congress of Urology, 01/10/2010
  • The usefulness of Prostate Specific Antigen Density in Prostate Cancer detection: A Malaysian perspective., Asian Congress of Urology, 27/08/2010
  • The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound (TRUS) biopsy of prostate: a prospective randomized trial., British Association of Urological Surgeons 2009 Annual Scientific Meeting, 26/06/2009 (International)
  • Three Dimensional Volume rendering of Computerized Tomography for the Detection of Radioluscent Small Calculi Adjacent to The Ureteric , 16th Malaysian Urological Conference, 07/12/2007 to 09/12/2007, Malaysian Urological Conference (National)
  • The Use of Various Prostate Specific Antigen (PSA) Forms for Estimation of Prostate Cancer Risk., 16th Malaysian Urological Conference, 07/12/2007 to 09/12/2007, Malaysian Urological Association (National)
  • Extracorporeal Shock Wave Lithotripsy Therapy in The University of Malaya Medical Centre, 15th Malaysian Urology Congress, 08/12/2006 to 10/12/2006, Malaysian Urological Association (National)
    • OTHERS
  • Organising Chairman, 27th Malaysian Urological Conference, 22/11/2018 to 24/11/2018, Malaysian Urological Association (National)
  • Assessment of diagnostic performance of Prostate Specific Antigen (PSA) in a nation of low prostate cancer incidence, Urological Society of Australia and New Zealand Annual Scientifc Meeting, 08/03/2009 to 12/03/2009, Urological Society of Australia and New Zealand (International)
  • The Use of Various Prostate Specific Antigen (PSA) Forms for Estimation of Prostate Cancer Risk, 9th Asian Congress of Urology, 02/10/2008 to 05/10/2008, Asian Congress of Urology (International)